This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.
- Investigator
- Angela Pham
- Status
- Accepting Candidates
- Ages
- 18 Years - 75 Years
- Sexes
- All
Update your location to show providers, locations, and services closest to you.
Gastroenterologist
This is a study to explore the effect of oral ozanimod as an induction treatment for participants with moderately to severely active Crohn's Disease.
10 publications
2024
ACG case reports journal
PubMed • Publisher's site2023
ACG case reports journal
PubMed • Publisher's site2023
Journal of investigative medicine high impact case reports
PubMed • Publisher's site2022
ACG case reports journal
PubMed • Publisher's site2022
Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition
PubMed • Publisher's site